Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever.
BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...
The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...
Both companies may succeed in this industry.
The companies will invest up to $1 billion over five years to support discovery and development powered by artificial ...
ONE AFTERNOON in the spring of the year 1910, Ben Lilly with five of his dogs swung off the caboose of a freight train at the ...
This biotech has candidates in late-stage clinical development.
6hon MSN
Eli Lilly (LLY) oncology pipeline and $1B Nvidia (NVDA) AI partnership signal strong 2026 growth
Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results